-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
Analgesic trials in children: safety, efficacy and innovation
Gary A Walco, Elliot J Krane & Charles B Berde
Editorial: Clinical Investigation
-
Analgesic trials in children: safety, efficacy and innovation
Gary A Walco, Elliot J Krane & Charles B Berde
Editorial: Clinical Investigation
-
Analgesic trials in children: safety, efficacy and innovation
Gary A Walco, Elliot J Krane & Charles B Berde
Editorial: Clinical Investigation
-
Analgesic trials in children: safety, efficacy and innovation
Gary A Walco, Elliot J Krane & Charles B Berde
Editorial: Clinical Investigation
-
Analgesic trials in children: safety, efficacy and innovation
Gary A Walco, Elliot J Krane & Charles B Berde
Editorial: Clinical Investigation
-
Analgesic trials in children: safety, efficacy and innovation
Gary A Walco, Elliot J Krane & Charles B Berde
Editorial: Clinical Investigation
-
Analgesic trials in children: safety, efficacy and innovation
Gary A Walco, Elliot J Krane & Charles B Berde
Editorial: Clinical Investigation
-
Analgesic trials in children: safety, efficacy and innovation
Gary A Walco, Elliot J Krane & Charles B Berde
Editorial: Clinical Investigation
-
The Role of Mipomersen Therapy in the Treatment of Familial Hypercholesterolemia
Roda Plakogiannis, Lisa Cioce, Edward A Fisher, James A Underberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
The Role of Mipomersen Therapy in the Treatment of Familial Hypercholesterolemia
Roda Plakogiannis, Lisa Cioce, Edward A Fisher, James A Underberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
The Role of Mipomersen Therapy in the Treatment of Familial Hypercholesterolemia
Roda Plakogiannis, Lisa Cioce, Edward A Fisher, James A Underberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
The Role of Mipomersen Therapy in the Treatment of Familial Hypercholesterolemia
Roda Plakogiannis, Lisa Cioce, Edward A Fisher, James A Underberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
The Role of Mipomersen Therapy in the Treatment of Familial Hypercholesterolemia
Roda Plakogiannis, Lisa Cioce, Edward A Fisher, James A Underberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
The Role of Mipomersen Therapy in the Treatment of Familial Hypercholesterolemia
Roda Plakogiannis, Lisa Cioce, Edward A Fisher, James A Underberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
The Role of Mipomersen Therapy in the Treatment of Familial Hypercholesterolemia
Roda Plakogiannis, Lisa Cioce, Edward A Fisher, James A Underberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
The Role of Mipomersen Therapy in the Treatment of Familial Hypercholesterolemia
Roda Plakogiannis, Lisa Cioce, Edward A Fisher, James A Underberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation